BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12711352)

  • 1. Kinetic studies on the inhibition of creatine kinase activity by branched-chain alpha-amino acids in the brain cortex of rats.
    Pilla C; Cardozo RF; Dornelles PK; Dutra-Filho CS; Wyse AT; Wajner M; Wannmacher CM
    Int J Dev Neurosci; 2003 May; 21(3):145-51. PubMed ID: 12711352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creatine kinase activity from rat brain is inhibited by branched-chain amino acids in vitro.
    Pilla C; Cardozo RF; Dutra-Filho CS; Wyse AT; Wajner M; Wannmacher CM
    Neurochem Res; 2003 May; 28(5):675-9. PubMed ID: 12716015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Creatine and antioxidant treatment prevent the inhibition of creatine kinase activity and the morphological alterations of C6 glioma cells induced by the branched-chain alpha-keto acids accumulating in maple syrup urine disease.
    Funchal C; Schuck PF; Santos AQ; Jacques-Silva MC; Gottfried C; Pessoa-Pureur R; Wajner M
    Cell Mol Neurobiol; 2006 Feb; 26(1):67-79. PubMed ID: 16633902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology of maple syrup urine disease: Focus on the neurotoxic role of the accumulated branched-chain amino acids and branched-chain α-keto acids.
    Amaral AU; Wajner M
    Neurochem Int; 2022 Jul; 157():105360. PubMed ID: 35577033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that the branched-chain alpha-keto acids accumulating in maple syrup urine disease induce morphological alterations and death in cultured astrocytes from rat cerebral cortex.
    Funchal C; Gottfried C; De Almeida LM; Wajner M; Pessoa-Pureur R
    Glia; 2004 Nov; 48(3):230-40. PubMed ID: 15390119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of leucine administration on creatine kinase activity in rat brain.
    Pilla C; de Oliveira Cardozo RF; Dutra-Filho CS; Wyse AT; Wajner M; Wannmacher CM
    Metab Brain Dis; 2003 Mar; 18(1):17-25. PubMed ID: 12603079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Branched-chain amino acids (BCAA) administration increases autophagy and the autophagic pathway in brain tissue of rats submitted to a Maple Syrup Urine Disease (MSUD) protocol.
    Fermo KT; da Silva Lemos I; Farias HR; Rosso MP; Effting PS; Leipnitz G; Streck EL
    Metab Brain Dis; 2023 Jan; 38(1):287-293. PubMed ID: 36305998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood and tissue branched-chain amino and alpha-keto acid concentrations: effect of diet, starvation, and disease.
    Hutson SM; Harper AE
    Am J Clin Nutr; 1981 Feb; 34(2):173-83. PubMed ID: 7211722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptotic signaling pathways induced by acute administration of branched-chain amino acids in an animal model of maple syrup urine disease.
    Vilela TC; Scaini G; Furlanetto CB; Pasquali MA; Santos JP; Gelain DP; Moreira JC; Schuck PF; Ferreira GC; Streck EL
    Metab Brain Dis; 2017 Feb; 32(1):115-122. PubMed ID: 27510712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of branched-chain amino acids alters epigenetic regulatory enzymes in an animal model of Maple Syrup Urine Disease.
    Streck EL; Bussular FP; Wessler LB; Duarte MB; Rezende VL; Rodrigues MS; Torres CA; Lemos IS; Candiotto G; Gava FF; de Oliveira J; Valvassori SS
    Metab Brain Dis; 2021 Feb; 36(2):247-254. PubMed ID: 33098071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective Effect of Creatine and Pyruvate on Enzyme Activities of Phosphoryl Transfer Network and Oxidative Stress Alterations Caused by Leucine Administration in Wistar Rats.
    Rieger E; de Franceschi ID; Preissler T; Wannmacher CMD
    Neurotox Res; 2017 Nov; 32(4):575-584. PubMed ID: 28612295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synaptic plasma membrane Na(+), K (+)-ATPase activity is significantly reduced by the alpha-keto acids accumulating in maple syrup urine disease in rat cerebral cortex.
    Wajner A; Bürger C; Dutra-Filho CS; Wajner M; de Souza Wyse AT; Wannmacher CM
    Metab Brain Dis; 2007 Mar; 22(1):77-88. PubMed ID: 17295076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of brain energy metabolism by the branched-chain amino acids accumulating in maple syrup urine disease.
    Ribeiro CA; Sgaravatti AM; Rosa RB; Schuck PF; Grando V; Schmidt AL; Ferreira GC; Perry ML; Dutra-Filho CS; Wajner M
    Neurochem Res; 2008 Jan; 33(1):114-24. PubMed ID: 17680360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of oxidative stress in rat brain by the metabolites accumulating in maple syrup urine disease.
    Bridi R; Araldi J; Sgarbi MB; Testa CG; Durigon K; Wajner M; Dutra-Filho CS
    Int J Dev Neurosci; 2003 Oct; 21(6):327-32. PubMed ID: 12927581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine.
    Riazi R; Rafii M; Clarke JT; Wykes LJ; Ball RO; Pencharz PB
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E142-9. PubMed ID: 14970005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the branched-chain alpha-keto acids accumulating in maple syrup urine disease on S100B release from glial cells.
    Funchal C; Tramontina F; Quincozes dos Santos A; Fraga de Souza D; Gonçalves CA; Pessoa-Pureur R; Wajner M
    J Neurol Sci; 2007 Sep; 260(1-2):87-94. PubMed ID: 17499767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological alterations and cell death provoked by the branched-chain alpha-amino acids accumulating in maple syrup urine disease in astrocytes from rat cerebral cortex.
    Funchal C; Gottfried C; de Almeida LM; dos Santos AQ; Wajner M; Pessoa-Pureur R
    Cell Mol Neurobiol; 2005 Aug; 25(5):851-67. PubMed ID: 16133938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Branched chain amino acids induce apoptosis in neural cells without mitochondrial membrane depolarization or cytochrome c release: implications for neurological impairment associated with maple syrup urine disease.
    Jouvet P; Rustin P; Taylor DL; Pocock JM; Felderhoff-Mueser U; Mazarakis ND; Sarraf C; Joashi U; Kozma M; Greenwood K; Edwards AD; Mehmet H
    Mol Biol Cell; 2000 May; 11(5):1919-32. PubMed ID: 10793161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coadministration of branched-chain amino acids and lipopolysaccharide causes matrix metalloproteinase activation and blood-brain barrier breakdown.
    Scaini G; Morais MO; Galant LS; Vuolo F; Dall'Igna DM; Pasquali MA; Ramos VM; Gelain DP; Moreira JC; Schuck PF; Ferreira GC; Soriano FG; Dal-Pizzol F; Streck EL
    Mol Neurobiol; 2014 Oct; 50(2):358-67. PubMed ID: 24390570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin ameliorates oxidative stress and DNA damage of rats subjected to a chemically induced chronic model of Maple Syrup Urine Disease.
    Wessler LB; Ise K; Lemos IC; Rezende VL; Duarte MB; Damiani AP; de Oliveira J; de Andrade VM; Streck EL
    Metab Brain Dis; 2020 Aug; 35(6):905-914. PubMed ID: 32297169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.